SEC Form 4 · accession 0000899243-16-021189
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henri A Termeer
Director
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 1:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.92 | May 26, 2016 | A | 20,000 | A | — | May 26, 2026 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (right to buy)F2 | $0.92 | May 26, 2016 | A | 44,021 | A | — | May 26, 2026 | Common Stock | 44,021 | 44,021 | D |
Explanation of responses
- F1This option vests in twelve equal monthly installments, with the first tranche exercisable on July 1, 2016.
- F2This option vests in four equal quarterly installments, commencing on January 1, 2016 and ending on December 31, 2016.
Remarks
Exhibit List Exhibit 24 - Power of Attorney